脑机接口进入临床并收费，有望加快行业落地运用

Industry Insights - The National Healthcare Security Administration (NHSA) has introduced a pricing mechanism for newly launched drugs and medical devices, adding over 100 pricing items related to new medical technologies to support innovation in the sector [1] - The NHSA aims to streamline the charging process for new technologies, facilitating quicker revenue returns for urgently needed clinical products [1] - The introduction of pricing items for brain-computer interface (BCI) technologies, such as "brain-computer interface implantation fee" and "brain-computer interface adaptation fee," is expected to accelerate the clinical application and commercialization of BCI technologies [1] - The global market for BCI medical applications is projected to reach $40 billion by 2030 and $145 billion by 2040, indicating significant growth potential in this sector [1] Company Developments - Entropy Technology has highlighted its core focus in the BCI field through its subsidiary, Entropy Cloud, which is developing multimodal data fusion and analysis technologies [2] - Innovative Medical, a company with stakes in BCI technology, has developed a B-end product, an upper limb exoskeleton active rehabilitation training system, which accurately identifies the active movement intentions of hemiplegic patients, enhancing rehabilitation training effectiveness [2]